Consolidation in TF wk is that's all I could say.
Modulating immune system play role in cancer and infection.
In cancer treatment targeted therapy and tailed play major role (High cost of drug of course)
CRVS do the modulating immune system thing
Now let's see what's CRVS do.
What the physicians want is "When can we use this medication/protocol?"
It's phase 3 to use in human before FDA approves
Phase 3 is important when you do research
Here what's they do
COVID
Phase 1 CPI-006 (B cell activation -> immune system thing about white blood cell)
CANCER
Phase 1B-2 Ciforadenant Renal cell, prostate
Phase 1 CPI 818 T-cell lymphoma (white blood cell cancer)
etc.
So the factors that the price will surge are:-
-Positive Research outcome
-Phase 3
-FDA approve
that's all